Llwytho...
The impact of direct-acting antiviral therapy for hepatitis C on hepatocellular carcinoma risk.
PURPOSE OF REVIEW: Direct-acting antiviral agents (DAAs) eradicate hepatitis C virus (HCV) infection in the majority of patients. We critically evaluated the impact of DAAs on hepatocellular carcinoma (HCC) risk, a major complication of HCV infection. RECENT FINDINGS: Large cohort studies show that...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Curr Hepatol Rep |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6433385/ https://ncbi.nlm.nih.gov/pubmed/30923667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11901-018-0424-8 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|